Integral Cognitive Remediation for Depression
INCREM
INtegral Cognitive REMediation for Depression (INCREM). Multicentric Randomized Clinical Trial to Investigate Feasibility and Efficacy (Phase II)
1 other identifier
interventional
101
1 country
1
Brief Summary
The goal of this clinical trial is to learn if INCREM intervention can improve psychosocial functioning in patients with remitted major depressive disorder. The main question it aims to answer are: Does INCREM improve psychosocial functioning compared to psychoeducation? Does the benefits of INCREM remain after six months of the intervention compared to psychoeducation? Researchers will compare two arms: INCREM; psychoeducation to see if psychosocial functioning improves. Participants will be allocated to:
- INCREM
- Psychoeducation
- TAU.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 19, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 13, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 13, 2023
CompletedFirst Submitted
Initial submission to the registry
May 30, 2025
CompletedFirst Posted
Study publicly available on registry
June 11, 2025
CompletedJune 11, 2025
September 1, 2024
1.9 years
May 30, 2025
May 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functioning Assessment Short Test (FAST)
The FAST is a valid, widely used instrument to test psychosocial functioning. The main outcome measure will be the percentage of change in FAST scores between T0 and T1 and T2.
From enrollment to the end of treatment (12 weeks) and to the end of follow-up (6 months)
Secondary Outcomes (3)
Hamilton Depression Rating Scale-17 items (HDRS_17)
From enrollment to the end of treatment (12 weeks) and to the end of follow-up (6 months)
Screening for Cognitive Impairment in Psychiatry (SCIP)
From enrollment to the end of the intervention (12 weeks) and to the end of the follow-up (6 months)
Perceived Deficits Questionnaire for Depression (PDQ-R)
From enrollment to the end of the intervention (12 weeks) and to the end of follow-up (6 months)
Study Arms (2)
INCREM
EXPERIMENTAL12-session integral cognitive remediation program specifically designed for depression.
Psychoeducation
ACTIVE COMPARATOR12-session psychoeducation program for depression
Interventions
This is a specifically designed program to improve psychosocial functioning which targets cognitive symptoms.
This is a 12-session psychoeducation program designed as an active comparator for the current trial
Eligibility Criteria
You may qualify if:
- Patients aged 18-60 y.o. and beyond with a remitted or active episode of major depression (DSM-5 criteria; maximum score of 18-20 on the HDRS-17) showing cognitive symptoms (scores below 80 on the SCIP) with functional difficulties (scores above 12 on the FAST).
You may not qualify if:
- IQ below 85;
- any unstable or inadequately-treated medical condition that may affect neuropsychological performance;
- being under drug treatment in the last 4 weeks with glucocorticoids, probiotics, non-steroidal anti-inflammatory drugs, bile acid sequestrants, immunosuppressive drugs, anti-histamines, mast cell stabilizers, and antioxidant supplements;
- use of systemic antibiotics the last 2 months;
- presence of any comorbid psychiatric condition, other than personality disorders or nicotine use disorders, in the last three months;
- accomplish criteria for severe treatment resistant depression;
- patients who had received electroconvulsive therapy in the previous year;
- patients receiving any other structured psychological intervention in the 3 months prior to the study;
- not having the necessary electronic means (computer or tablet) or internet connection to be able to participate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institut de Recerca Sant Pau- Mental Health Group
Barcelona, Catalonia, 08041, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maria J Portella, Dr
Fundació Institut de Recerca Hospital de la Santa Creu i Sant Pau
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 30, 2025
First Posted
June 11, 2025
Study Start
September 19, 2021
Primary Completion
August 13, 2023
Study Completion
August 13, 2023
Last Updated
June 11, 2025
Record last verified: 2024-09